COMMONWEALTH BANK OF AUSTRALIA - BAXTER INTL INC ownership

BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,056 filers reported holding BAXTER INTL INC in Q1 2018. The put-call ratio across all filers is 0.59 and the average weighting 0.3%.

About BAXTER INTL INC

Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.

Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.

Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.

Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.

Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
COMMONWEALTH BANK OF AUSTRALIA ownership history of BAXTER INTL INC
ValueSharesWeighting
Q2 2019$4,250,000
-4.0%
51,954
-4.7%
0.04%
-2.4%
Q1 2019$4,427,000
+23.1%
54,521
-0.4%
0.04%
+5.0%
Q4 2018$3,595,000
-13.6%
54,721
+1.2%
0.04%0.0%
Q3 2018$4,162,000
+8.0%
54,068
+3.4%
0.04%
+2.6%
Q2 2018$3,853,000
-7.1%
52,268
-18.2%
0.04%
-13.3%
Q1 2018$4,149,000
-12.3%
63,894
-12.8%
0.04%
-2.2%
Q4 2017$4,732,000
-5.4%
73,314
-8.2%
0.05%
-6.1%
Q3 2017$5,003,000
+6.5%
79,823
+2.8%
0.05%
+4.3%
Q2 2017$4,699,000
+14.8%
77,637
-1.6%
0.05%
+4.4%
Q1 2017$4,094,000
+12.8%
78,919
-3.6%
0.04%
+2.3%
Q4 2016$3,629,000
-90.6%
81,849
-89.9%
0.04%
-90.3%
Q3 2016$38,403,000
-45.1%
806,795
-47.9%
0.46%
-44.6%
Q2 2016$69,983,000
+11.1%
1,547,601
+0.9%
0.82%
+7.0%
Q1 2016$62,978,000
+33.2%
1,533,043
+23.7%
0.77%
+26.7%
Q4 2015$47,287,000
+16.2%
1,239,515
+0.1%
0.61%
+16.8%
Q3 2015$40,686,000
-53.4%
1,238,528
-0.8%
0.52%
-55.3%
Q2 2015$87,346,000
-0.8%
1,249,049
-2.9%
1.16%
-2.4%
Q1 2015$88,078,000
-12.9%
1,285,806
-6.8%
1.19%
-16.9%
Q4 2014$101,091,000
+6.9%
1,379,316
+4.7%
1.43%
+16.9%
Q3 2014$94,552,000
+13.1%
1,317,443
+14.0%
1.22%
+8.9%
Q2 2014$83,566,000
-37.3%
1,155,810
-36.2%
1.12%
+32.0%
Q1 2014$133,254,000
+67.5%
1,810,993
+58.3%
0.85%
+56.0%
Q4 2013$79,550,000
+47.6%
1,143,783
+39.4%
0.55%
+39.6%
Q3 2013$53,883,000
-1.8%
820,289
+3.5%
0.39%
-5.3%
Q2 2013$54,885,000792,3370.41%
Other shareholders
BAXTER INTL INC shareholders Q1 2018
NameSharesValueWeighting ↓
Tri Locum Partners LP 298,721$23,969,0008.70%
GENERATION INVESTMENT MANAGEMENT LLP 17,424,560$1,398,147,0006.24%
Soditic Asset Management LLP 77,950$6,255,0006.24%
Veritas Asset Management LLP 11,110,132$891,477,0005.32%
Dash Acquisitions Inc. 84,560$6,785,0004.74%
Prosight Management, LP 121,075$9,715,0004.49%
TSFG, LLC 94,977$7,621,0004.07%
CINCINNATI FINANCIAL CORP 1,344,648$107,895,0002.93%
Dundas Partners LLP 204,535$19,304,0002.82%
Unified Trust Company, N.A. 59,491$4,689,0002.72%
View complete list of BAXTER INTL INC shareholders